2Viereck V, Emons G, Wuttke W. Black cohosh: just ariother phytoestrogen? Trends Endocrinol Metab, 2005,16:214-221.
3Nappi RE, Malavasi B, Brundu B, et al. Efficacy of Cimieifuga racemosa on climacteric complaints: a randomized study versus lowdose transdermal estradiol. Gynecol Endocrinol, 2005,20:30-35.
4Kenemans P, Speroff L, International Tibolone Consensus Group. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas, 2005,51:21-28.
5Powell SL, Godecke T, Nikolic D, et al. In vitro serotonergic activity of black cohosh and identification of N (omega)- methylserotonin as a potential active constituent. J Agric Food Chem, 2008,56 : 11718-11726.
6Pockaj BA, Gallagher JG, Loprinzi CL, et al. Phase Ⅲ doubleblind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial NO1CC1. J Clin Oncol, 2006,24:2836-2841.
7Osmers R, Friede M, Liske E, et al. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol, 2005,105 : 1074-1083.
8Christodoulakos GE, Botsis DS, Lambrinoudaki IV, et al. A 5- year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness. Maturitas, 2006, 53:413-423.
9Kurtay G, Berker B, Demirel C. Transvaginal ultrasonographic assessment of the endometrium in asymptomatic, postmenopausal women using different HRT regimens containing tibolone or estrogen. J Reprod Med, 2004,49:893-898.
10Hirschberg AL, Edlund M, Svane G, et al. An isopropanolic extract of black cohosh does not increase mammogTaphic breast density or breast cell proliferation in postmenopausal women. Menopause, 2007,14 : 89-96.
9Singh P, Oehler MK. Hormone replacement after gynaeeological cancer [ J]. Maturitas,2010,65(3) :190 - 197.
10Poilblanc M, Samouelian V, Querleu D. Ovarian preservation during treatment of early stage endometrial cancer[ J ]. Bull Canner,2012,99 ( 1 ) :61 - 68.
